Investigating the synergistic mechanism between ibrutinib and daunorubicin in acute myeloid leukemia cells.

Rotin LE, Gronda M, Hurren R, Wang X, Minden MD, Slassi M, Schimmer AD

Open source

DOI
10.3109/10428194.2016.1138292
Published
2016 Oct
Container
Leukemia & lymphoma
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3109/10428194.2016.1138292,
  title = {Investigating the synergistic mechanism between ibrutinib and daunorubicin in acute myeloid leukemia cells.},
  author = {Rotin LE and Gronda M and Hurren R and Wang X and Minden MD and Slassi M and Schimmer AD},
  year = {2016},
  journal = {Leukemia \& lymphoma},
  doi = {10.3109/10428194.2016.1138292},
  url = {https://doi.org/10.3109/10428194.2016.1138292}
}

RIS

TY  - JOUR
TI  - Investigating the synergistic mechanism between ibrutinib and daunorubicin in acute myeloid leukemia cells.
AU  - Rotin LE
AU  - Gronda M
AU  - Hurren R
AU  - Wang X
AU  - Minden MD
AU  - Slassi M
AU  - Schimmer AD
PY  - 2016
JO  - Leukemia & lymphoma
DO  - 10.3109/10428194.2016.1138292
UR  - https://doi.org/10.3109/10428194.2016.1138292
ER  - 

APA

LE, R., M, G., R, H., X, W., MD, M., M, S., & AD, S. (2016). Investigating the synergistic mechanism between ibrutinib and daunorubicin in acute myeloid leukemia cells.. Leukemia & lymphoma. https://doi.org/10.3109/10428194.2016.1138292

Source records